These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20030863)

  • 1. Next-generation sequencing.
    Reis-Filho JS
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S12. PubMed ID: 20030863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer genome analysis through next-generation sequencing].
    Aburatani H
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complete genome of an individual by massively parallel DNA sequencing.
    Wheeler DA; Srinivasan M; Egholm M; Shen Y; Chen L; McGuire A; He W; Chen YJ; Makhijani V; Roth GT; Gomes X; Tartaro K; Niazi F; Turcotte CL; Irzyk GP; Lupski JR; Chinault C; Song XZ; Liu Y; Yuan Y; Nazareth L; Qin X; Muzny DM; Margulies M; Weinstock GM; Gibbs RA; Rothberg JM
    Nature; 2008 Apr; 452(7189):872-6. PubMed ID: 18421352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines.
    Hampton OA; Koriabine M; Miller CA; Coarfa C; Li J; Den Hollander P; Schoenherr C; Carbone L; Nefedov M; Ten Hallers BF; Lee AV; De Jong PJ; Milosavljevic A
    Cancer Genet; 2011 Aug; 204(8):447-57. PubMed ID: 21962895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cancer Genome Atlas: clinical applications for breast cancer.
    Ma CX; Ellis MJ
    Oncology (Williston Park); 2013 Dec; 27(12):1263-9, 1274-9. PubMed ID: 24624545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the cancer genome in the era of next-generation sequencing.
    Dong H; Wang S
    Front Med; 2012 Mar; 6(1):48-55. PubMed ID: 22460448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.
    Ross JS; Gay LM
    Pathology; 2017 Feb; 49(2):120-132. PubMed ID: 28034454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation DNA sequencing methods.
    Mardis ER
    Annu Rev Genomics Hum Genet; 2008; 9():387-402. PubMed ID: 18576944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of next-generation sequencing versus the microarray in epigenetic research.
    Hurd PJ; Nelson CJ
    Brief Funct Genomic Proteomic; 2009 May; 8(3):174-83. PubMed ID: 19535508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Genome Sequencing at the Population Scale: A Primer on High-Throughput DNA Sequencing and Analysis.
    Goldfeder RL; Wall DP; Khoury MJ; Ioannidis JPA; Ashley EA
    Am J Epidemiol; 2017 Oct; 186(8):1000-1009. PubMed ID: 29040395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research and clinical applications of cancer genome sequencing.
    Ku CS; Cooper DN; Ziogas DE; Halkia E; Tzaphlidou M; Roukos DH
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):3-10. PubMed ID: 23108289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative technology for cancer risk analysis.
    Tommasi S; Danza K; Pilato B; De Summa S
    Ann Oncol; 2011 Jan; 22 Suppl 1():i37-43. PubMed ID: 21285149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.
    Palculict ME; Zhang VW; Wong LJ; Wang J
    Methods Mol Biol; 2016; 1351():3-17. PubMed ID: 26530670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing a re-sequencing DNA library of 2 cancer candidate genes using the ligation-by-amplification protocol by two PCR reactions.
    Su Y; Lin L; Tian G; Chen C; Liu T; Xu X; Qi X; Zhang X; Yang H
    Sci China C Life Sci; 2009 May; 52(5):483-91. PubMed ID: 19471873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors.
    Morozova O; Marra MA
    Biochem Cell Biol; 2008 Apr; 86(2):81-91. PubMed ID: 18443621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.
    Schweiger MR; Kerick M; Timmermann B; Isau M
    Cancer Metastasis Rev; 2011 Jun; 30(2):199-210. PubMed ID: 21267768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep sequencing in cancer research.
    Yoshida K; Sanada M; Ogawa S
    Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.